Zydus Secures Final USFDA Approval for Ammonium Lactate Cream, Expands Generics Basket
Written By : Parthika Patel
Published On 2026-02-16 09:52 GMT | Update On 2026-02-16 09:52 GMT
Advertisement
New Delhi: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Ammonium Lactate Cream, 12%, further strengthening its dermatology portfolio in the United States market.
The company, in a regulatory filing, said that it has secured final approval for Ammonium Lactate Cream, 12% (USRLD: Lac-Hydrin Cream®, 12%).
Ammonium Lactate Cream, 12% is a topical prescription medication indicated for the treatment of dry, scaly skin (xerosis) and an inherited dry skin condition known as ichthyosis vulgaris. The cream works by increasing skin hydration and, as an alpha-hydroxy acid, helps relieve itching, soften the skin, and reduce scaling.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.